2[1]Udoff LC, Adashi EY. Polycystic ovary disease: current insights into an old problem. J Pediat Adoles Gynecol, 1996,9:3-8.
3[2]Berga SL. The obstetrician: gynecologist role in the practical management of polycystic ovary syndrome. Am J Obstet Gynecol, 1998,S109-113.
4[3]Dale PO, Tanbo T, Valer S, et al. Body weight, hyperinsulinemia and gonadotropin levels in the polycystic ovary syndrome: evidence of two distinct populations. Fertil Steril, 1992,58:487-491.
5[4]Wild RA, Grubb B, Hartz A, et al. Clinical signs of androgen excess as risk factors for coronary artery disease. Fertil Steril, 1990,54:255-259.
6[5]Porestsky L, Piper V. Insulin resistance, hypersecretion of LH, a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome. Obstet Gynecol, 1994,84:613-621.
7[6]Pasquali R, Casimirri F. The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women. Clin Endocrinol, 1993,39:1-16.
8[7]Pettigrew R, Hamiton-Fairly D. Obesity and female reproductive function. Br Med Bull, 1997,53:341-358.
9[8]Jakubowiez DS, Nestler JE. 17 alpha-hydroxy progesterone responses to leuprolide and serum androgens in obese women with and without polycystic ovary syndrome offer dietary weight loss. J Clin Endocrinol Metab, 1997,82:556-560.
10[9]Guzick DS, Wing R, Smith D, et al. Endocrine consequences of weight loss in obese hyperandrogenic anovulatory women. Fertil Steril, 1994,61:598-604.
